While this result is not fully explaining the extraordinary difference in binding properties it is clear that the positive inhibitor charge contributes substantially to the selectivity of fascaplysin to CDK4. This has important implications for the design of fascaplysin derived CDK4 inhibitors, a positive charge should be kept in derivatives. Interestingly, the highly specific CDK4 inhibitor PD0332991 bears a tertiary amine and hence also a positive charge. It may achieve, at least partially, its specificity also via differential stabilisation of the positive charge. The molecular modelling study in this work addresses the 1800401-93-7 remarkable selectivity of fascaplysin for CDK4. We have established a ��hybrid model approach for CDK4 as a suitable starting point for ligand docking and molecular dynamics studies. Thermodynamic integration focussing on the effect of the positive charge on fascaplysin demonstrates that this charge significantly contributes to fascaplysin selectivity, while additional factors such as the polar interaction with His95CDK4 may also play a role. Molecular dynamics simulations indicate that the molecular basis of this effect may be due to an unfavourable interaction with Lys89CDK2. Our study suggests that there is a significant gain in specificity to be made by incorporating/maintaining a positively charged functional group when designing inhibitors selective for CDK4. The phosphoinositide 3-kinase family Eleutheroside E distributor includes lipid kinases that catalyze the phosphorylation of the 39-hydroxyl group of phosphatidylinositols to generate second messengers, such as phosphatidylinositol-3,4,5- triphosphate. PIP3 recruits downstream effectors along the PI3K/protein kinase B/mammalian target of rapamycin signaling cascade that is of crucial importance for the regulation of cellular growth, survival, and proliferation. Based on sequence homology and substrate preference, PI3Ks are divided into three classes. Class I PI3Ks are subdivided into four isoforms, PI3Ka, PI3Kb, PI3Kd, and PI3Kc, according to different activation mechanism and varied catalytic and regulatory subunits. Many studies have demonstrated that gain-of-function mutations in the gene encoding the catalytic subunit of PI3Ka, PIK3CA, amplification of PIK3CA, and loss
